Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1527-7755

Journal

More filtering options
  1. Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate.

    Abrahamsson, J., Forestier, E., Heldrup, J., Jahnukainen, K., Jónsson, O. G., Lausen, B., Palle, J., Zeller, B. & Hasle, H., 2011, In : Journal of Clinical Oncology. 29, p. 310-315

    Research output: Contribution to journalArticle

  2. Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study.

    Agudo, A., Bonet, C., Travier, N., González, C. A., Vineis, P., Bueno-de-Mesquita, H. B., Trichopoulos, D., Boffetta, P., Clavel-Chapelon, F., Boutron-Ruault, M-C., Kaaks, R., Lukanova, A., Schütze, M., Boeing, H., Tjonneland, A., Halkjaer, J., Overvad, K., Dahm, C. C., Quirós, J. R., Sánchez, M-J. & 25 othersLarrañaga, N., Navarro, C., Ardanaz, E., Khaw, K-T., Wareham, N. J., Key, T. J., Allen, N. E., Trichopoulou, A., Lagiou, P., Palli, D., Sieri, S., Tumino, R., Panico, S., Boshuizen, H., Büchner, F. L., Peeters, P. H. M., Signe Borgquist, Martin Almquist, Hallmans, G., Johansson, I., Gram, I. T., Lund, E., Weiderpass, E., Romieu, I. & Riboli, E., 2012, In : Journal of Clinical Oncology.

    Research output: Contribution to journalArticle

  3. Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma.

    Andersen, N. S., Pedersen, L. B., Laurell, A., Elonen, E., Kolstad, A., Boesen, A. M., Pedersen, L. M., Lauritzsen, G. F., Ekanger, R., Nilsson-Ehle, H., Nordström, M., Fredén, S., Mats Jerkeman, Mikael Eriksson, Väärt, J., Malmer, B. & Geisler, C. H., 2009, In : Journal of Clinical Oncology. 27, p. 4365-4370

    Research output: Contribution to journalArticle

  4. Tumor karyotype predicts clinical outcome in colorectal cancer patients

    Bardi, G., Fenger, C., Bertil Johansson, Felix Mitelman & Heim, S., 2004, In : Journal of Clinical Oncology. 22, 13, p. 2623-2634

    Research output: Contribution to journalArticle

  5. Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types

    Baselga, J., Rischin, D., Ranson, M., Calvert, H., Raymond, E., Kieback, D. G., Kaye, S. B., Gianni, L., Harris, A., Thomas Björk, Averbuch, S. D., Feyereislova, A., Swaisland, H., Rojo, F. & Albanell, J., 2002, In : Journal of Clinical Oncology. 20, 21, p. 4292-4302

    Research output: Contribution to journalArticle

  6. Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy.

    Baumann, P., Nyman, J., Hoyer, M., Wennberg, B., Gagliardi, G., Lax, I., Drugge, N., Ekberg, L., Friesland, S., Johansson, K-A., Lund, J-Å., Morhed, E., Nilsson, K., Levin, N., Paludan, M., Sederholm, C., Traberg, A., Wittgren, L. & Lewensohn, R., 2009, In : Journal of Clinical Oncology. 27, p. 3290-3296

    Research output: Contribution to journalArticle

  7. Distrust in the end-of-life care provided to a parent and long-term negative outcomes among bereaved adolescents: A population-based survey study

    Beernaert, K., Kreicbergs, U., Carl Johan Fürst, Nyberg, T., Steineck, G. & Bylund-Grenklo, T., 2017 Sep 20, In : Journal of Clinical Oncology. 35, 27, p. 3136-3142

    Research output: Contribution to journalReview article

  8. FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone as First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer.

    Bergh, J., Jönsson, P-E., Lidbrink, E. K., Trudeau, M., Eiermann, W., Brattström, D., Lindemann, J. P. O., Wiklund, F. & Henriksson, R., 2012, In : Journal of Clinical Oncology. 30, 16, p. 1919-1925

    Research output: Contribution to journalArticle

  9. Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study

    Biccler, J. L., Glimelius, I., Eloranta, S., Smeland, K. B., Brown, P. D. N., Jakobsen, L. H., Frederiksen, H., Mats Jerkeman, Fosså, A., Andersson, T. M. L., Holte, H., Bøgsted, M., El-Galaly, T. C. & Smedby, K. E., 2019 Mar 20, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 9, p. 703-713 11 p.

    Research output: Contribution to journalArticle

  10. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

    Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., Pápai, Z., Meyer, J., Nadel, H., Randall, R. L., Deffenbaugh, C., Nagarajan, R., Brennan, B., Letson, G. D., Teot, L. A., Goorin, A., Baumhoer, D., Kager, L. & 29 othersWerner, M., Lau, C. C., Sundby Hall, K., Gelderblom, H., Meyers, P., Gorlick, R., Windhager, R., Helmke, K., Mikael Eriksson, Hoogerbrugge, P. M., Schomberg, P., Tunn, P-U., Kühne, T., Jürgens, H., van den Berg, H., Böhling, T., Picton, S., Renard, M., Reichardt, P., Gerss, J., Butterfass-Bahloul, T., Morris, C., Hogendoorn, P. C. W., Seddon, B., Calaminus, G., Michelagnoli, M., Dhooge, C., Sydes, M. R. & Bernstein, M., 2015, In : Journal of Clinical Oncology. 33, 20, p. 2279-U92

    Research output: Contribution to journalArticle

  11. Digoxin use and the risk of breast cancer in women

    Biggar, R. J., Wohlfahrt, J., Anna Oudin, Hjuler, T. & Melbye, M., 2011, In : Journal of Clinical Oncology. 29, 16, p. 2165-2170 6 p.

    Research output: Contribution to journalArticle

  12. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35

    Bjordal, K., Hammerlid, E., Ahlner-Elmqvist, M., de Graeff, A., Boysen, M., Evensen, J. F., Biörklund, A., de Leeuw, J. R., Fayers, P. M., Magnus Jannert, Westin, T. & Kaasa, S., 1999, In : Journal of Clinical Oncology. 17, 3, p. 1008-1019

    Research output: Contribution to journalArticle

  13. Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008.

    Björkholm, M., Ohm, L., Eloranta, S., Derolf, A., Hultcrantz, M., Sjöberg, J., Andersson, T., Höglund, M., Johan Richter, Landgren, O., Kristinsson, S. Y. & Dickman, P. W., 2011, In : Journal of Clinical Oncology. 29, p. 2514-2520

    Research output: Contribution to journalArticle

  14. Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study

    Signe Borgquist, Giobbie-Hurder, A., Ahern, T. P., Garber, J. E., Colleoni, M., Láng, I., Debled, M., Ejlertsen, B., Von Moos, R., Smith, I. E., Coates, A. S., Goldhirsch, A., Rabaglio, M., Price, K. N., Gelber, R. D., Regan, M. M. & Thürlimann, B., 2017 Apr 10, In : Journal of Clinical Oncology. 35, 11, p. 1179-1188 10 p.

    Research output: Contribution to journalArticle

  15. Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group.

    Brekke, H. R., Ribeiro, F. R., Kolberg, M., Agesen, T. H., Lind, G. E., Eknæs, M., Hall, K. S., Bjerkehagen, B., van den Berg, E., Teixeira, M. R., Nils Mandahl, Smeland, S., Fredrik Mertens, Skotheim, R. I. & Lothe, R. A., 2010, In : Journal of Clinical Oncology. 28, p. 1573-1582

    Research output: Contribution to journalArticle

  16. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: A report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group

    Brohet, R. M., Goldgar, D. E., Easton, D. F., Antoniou, A. C., Andrieu, N., Chang-Claude, J., Peock, S., Eeles, R. A., Cook, M., Chu, C., Nogues, C., Lasset, C., Berthet, P., Meijers-Heijboer, H., Gerdes, A-M., Håkan Olsson, Caldes, T., van Leeuwen, F. E. & Rookus, M. A., 2007, In : Journal of Clinical Oncology. 25, 25, p. 3831-3836

    Research output: Contribution to journalArticle

  17. Physiological and Metabolic MR Imaging in gliomas

    Cao, Y., Pia Sundgren, Tsien, C., Junck, L. & Chenevert, TL., 2006, In : Journal of Clinical Oncology. 24, 8, p. 1228-1235

    Research output: Contribution to journalArticle

  18. Prostate Cancer Screening: Facts, Statistics, and Interpretation in Response to the US Preventive Services Task Force Review

    Carlsson, S., Vickers, A. J., Roobol, M., Eastham, J., Scardino, P., Hans Lilja & Hugosson, J., 2012, In : Journal of Clinical Oncology. 30, 21, p. 2581-2584

    Research output: Contribution to journalDebate/Note/Editorial

  19. Gain of 1q as a prognostic biomarker in Wilms Tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial: A SIOP renal tumours biology consortium study

    Chagtai, T., Zill, C., Dainese, L., Wegert, J., Savola, S., Popov, S., Mifsud, W., Vujanić, G., Sebire, N., Le Bouc, Y., Ambros, P. F., Kager, L., O'Sullivan, M. J., Blaise, A., Bergeron, C., Mengelbier, L. H., Gisselsson, D., Kool, M., Tytgat, G. A. M., Van Den Heuvel-Eibrink, M. M. & 6 othersGraf, N., Van Tinteren, H., Coulomb, A., Gessler, M., Williams, R. D. & Pritchard-Jones, K., 2016 Sep 10, In : Journal of Clinical Oncology. 34, 26, p. 3195-3203 9 p.

    Research output: Contribution to journalArticle

  20. Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis.

    Collins, M., Wilhelm, M., Conyers, R., Herschtal, A., Whelan, J., Bielack, S., Kager, L., Kühne, T., Sydes, M., Gelderblom, H., Ferrari, S., Picci, P., Smeland, S. E. R., Mikael Eriksson, Petrilli, A. S., Bleyer, A. & Thomas, D. M., 2013, In : Journal of Clinical Oncology. 31, 18, p. 2303-U130

    Research output: Contribution to journalArticle

  21. Upfront Autologuos Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01.

    d'Amore, F., Relander, T., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Osterborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Ostenstad, B., Fagerli, U-M., Gadeberg, O. V., Sundström, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H. E., 2012, In : Journal of Clinical Oncology. 30, 25, p. 3093-3099

    Research output: Contribution to journalArticle

  22. Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma

    Dantonello, T. M., Int-Veen, C., Winkler, P., Leuschner, I., Schuck, A., Schmidt, B. F., Lochbuehler, H., Kirsch, S., Hallmen, E., Veit-Friedrich, I., Bielack, S. S., Niggli, F., Kazanowska, B., Ladenstein, R., Thomas Wiebe, Klingebiel, T., Treuner, J. & Koscielniak, E., 2008, In : Journal of Clinical Oncology. 26, 3, p. 406-413

    Research output: Contribution to journalArticle

  23. Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer

    Domchek, S. M., Mitchell, G., Lindeman, G. J., Tung, N. M., Balmana, J., Isakoff, S. J., Schmutzler, R., Audeh, M. W., Niklas Loman, Scott, C., Friedlander, M., Kaufman, B., Garber, J. E., Tutt, A. & Robson, M. E., 2011, In : Journal of Clinical Oncology. 29, 32, p. 4224-4226

    Research output: Contribution to journalDebate/Note/Editorial

  24. Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.

    El-Galaly, T. C., Jakobsen, L. H., Hutchings, M., de Nully Brown, P., Nilsson-Ehle, H., Erzsébet Szekely, Mylam, K. J., Hjalmar, V., Johnsen, H. E., Bøgsted, M. & Mats Jerkeman, 2015, In : Journal of Clinical Oncology. 33, 34, p. 3993-3998

    Research output: Contribution to journalArticle

  25. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from sweden.

    Eriksson, H., Lyth, J., Månsson-Brahme, E., Frohm-Nilsson, M., Christian Ingvar, Lindholm, C., Naredi, P., Stierner, U., Carstensen, J. & Hansson, J., 2014, In : Journal of Clinical Oncology. 32, 13, p. 1356

    Research output: Contribution to journalArticle

  26. Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.

    Escudier, B., Roigas, J., Gillessen, S., Harmenberg, U., Srinivas, S., Mulder, S. F., Fountzilas, G., Peschel, C., Flodgren, P., Maneval, E. C., Chen, I. & Vogelzang, N. J., 2009, In : Journal of Clinical Oncology. 27, 25, p. 4068-4075

    Research output: Contribution to journalArticle

  27. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups

    Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Thor Alvegård, Picci, P., Capanna, R., Bernini, G., Muller, C., Tienghi, A., Thomas Wiebe, Comandone, A., Bohling, T., Del Prever, AB., Brosjo, O., Bacci, G. & Saeter, G., 2005, In : Journal of Clinical Oncology. 23, 34, p. 8845-8852

    Research output: Contribution to journalArticle

  28. A European treatment protocol for bone sarcoma in patients older than 40 years

    Ferrari, S., Smeland, S., Bielack, S., Comandone, A., Dileo, P., Picci, P., Hall, K. S., Mikael Eriksson, Honegger, H. & Reichardt, P., 2009, In : Journal of Clinical Oncology. 27, 15

    Research output: Contribution to journalPublished meeting abstract

  29. Outcome of men with relapse after adjuvant carboplatin for clinical stage i seminoma

    Fischer, S., Tandstad, T., Wheater, M., Porfiri, E., Fléchon, A., Aparicio, J., Klingbiel, D., Skrbinc, B., Basso, U., Shamash, J., Lorch, A., Dieckmann, K-P., Cohn-Cedermark, G., Ståhl, O., Chau, C., Arriola, E., Marti, K., Hutton, P., Laguerre, B., Maroto, P. & 2 othersBeyer, J. & Gillessen, S., 2017 Jan 10, In : Journal of Clinical Oncology. 35, 2, p. 194-200 7 p.

    Research output: Contribution to journalArticle

  30. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification

    Fletcher, C. D. M., Pelle Gustafson, Anders Rydholm, Willen, H. & Åkerman, M., 2001, In : Journal of Clinical Oncology. 19, 12, p. 3045-3050

    Research output: Contribution to journalArticle

  31. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.

    Gaspar, N., Hawkins, D. S., Dirksen, U., Lewis, I. J., Ferrari, S., Le Deley, M-C., Kovar, H., Grimer, R., Whelan, J., Claude, L., Delattre, O., Paulussen, M., Picci, P., Sundby Hall, K., van den Berg, H., Ladenstein, R., Michon, J., Hjorth, L., Judson, I., Luksch, R. & 7 othersBernstein, M. L., Marec-Bérard, P., Brennan, B., Craft, A. W., Womer, R. B., Juergens, H. & Oberlin, O., 2015, In : Journal of Clinical Oncology. 33, 27, p. 3036-U140

    Research output: Contribution to journalReview article

  32. Childhood cancer survival trends in Europe: a EUROCARE Working Group study

    Gatta, G., Capocaccia, R., Stiller, C., Kaatsch, P., Berrino, F., Terenziani, M., Storm, H. H., Aareleid, T., Hakulinen, T., Hédelin, G., Tron, I., Le Gall, E., Launoy, G., Macé-Lesech, J., Faivre, J., Chaplain, G., Carli, P-M., Lacour, B., Berger, C., Freycon, F. & 51 othersEstève, J., Tryggvadottir, L., Allemani, C., Baili, P., Ciccolallo, L., Micheli, A., Sant, M., Taussig, E., Carrani, E., De Angelis, R., Roazzi, P., Santaquilani, M., Tavilla, A., Valente, F., Verdecchia, A., Ferretti, S., Crosignani, P., Tagliabue, G., Ramazzotti, V., Cercato, M. C., Vercelli, M., Orengo, A., De Lisi, V., Serventi, L., Magnani, C., Pastore, G., Gafa`, L., Tumino, R., Paci, E., Crocetti, E., Langmark, F., Andersen, A., Rachtan, J., Plesˇko, I., Obsitníkova´, A., Pompe-Kirn, V., Ardanaz, E., Moreno, C., Galceran, J., Torrella, A., Peris-Bonet, R., Barlow, L., Möller, T., Jundt, G., Lutz, J-M., Usel, M., Coebergh, J. W. W., Coleman, M. P., Steward, J. A., Black, R. & Brewster, D., 2005, In : Journal of Clinical Oncology. 23, 16, p. 3742-3751

    Research output: Contribution to journalArticle

  33. Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)

    Greil, R., Letocha, H., Gamelin, E., Thaler, J., Hofheinz, R., Mineur, L., Fernebro, E., Karthaus, M., Wright, L. & Koehne, C., 2009, In : Journal of Clinical Oncology. 27, 15

    Research output: Contribution to journalPublished meeting abstract

  34. International Staging System for Multiple Myeloma.

    Greipp, P. R., San Miguel, J., Durie, B. G. M., Crowley, J. J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J. A., Harousseau, J-L., Kyle, R. A., Lahuerta, J. J., Ludwig, H., Morgan, G., Powles, R., Shimizu, K., Shustik, C., Sonneveld, P., Tosi, P., Ingemar Turesson & Westin, J., 2005, In : Journal of Clinical Oncology. 23, 15, p. 3412-3420

    Research output: Contribution to journalArticle

  35. Communication and Trust in the Care Provided to a Dying Parent: A Nationwide Study of Cancer-Bereaved Youths.

    Grenklo, T. B., Kreicbergs, U. C., Valdimarsdóttir, U. A., Nyberg, T., Steineck, G. & Carl Johan Fürst, 2013, In : Journal of Clinical Oncology.

    Research output: Contribution to journalArticle

  36. Functional Diffusion map (fDM) as an early imaging biomarker for high grade glioma: Correlation with conventional radiographic response and overall survival.

    Hamstra, D., Galban, C., Ross, DJ., Meyer, CR., Johnson, TD., Pia Sundgren, Tsien, C., Lawrence, TS., Junck, L., Rehemtulla, A., Ross, BD. & Chenevert, TL., 2008, In : Journal of Clinical Oncology. 26, 20, p. 3387-3394

    Research output: Contribution to journalArticle

  37. Suicide among survivors of childhood cancer

    Hawkins, M. M., Mertens, A. C., Möller, T. & Garwicz, S., 2007, In : Journal of Clinical Oncology. 25, 6, p. 731-732

    Research output: Contribution to journalLetter

  38. Collection and Use of Family History in Oncology Clinics.

    Kari Hemminki, Mahdi Fallah & Hemminki, A., 2014, In : Journal of Clinical Oncology. 32, 29, p. 3344

    Research output: Contribution to journalLetter

  39. Familial risks in cancer of unknown primary: tracking the primary sites.

    Kari Hemminki, Jianguang Ji, Jan Sundquist & Shu, X., 2011, In : Journal of Clinical Oncology. 29, 4, p. 435-440

    Research output: Contribution to journalArticle

  40. Familial Mortality and Familial Incidence in Cancer.

    Kari Hemminki, Jan Sundquist & Brandt, A., 2011, In : Journal of Clinical Oncology. 29, p. 712-718

    Research output: Contribution to journalArticle

  41. Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: A Randomized phase III trial

    Hermes, A., Bergman, B., Bremnes, R., Ek, L., Fluge, S., Sederholm, C., Sundstrom, S., Thaning, L., Vilsvik, J., Aasebo, U. & Soerenson, S., 2008, In : Journal of Clinical Oncology. 26, 26, p. 4261-4267

    Research output: Contribution to journalArticle

  42. Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast.

    Holmberg, L., Garmo, H., Granstrand, B., Anita Ringberg, Arnesson, L-G., Sandelin, K., Karlsson, P., Anderson, H. & Emdin, S., 2008, In : Journal of Clinical Oncology. 26, p. 1247-1252

    Research output: Contribution to journalArticle

  43. Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

    Joensuu, H., Mikael Eriksson, Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., Ramadori, G., Hohenberger, P., Al-Batran, S-E., Schlemmer, M., Bauer, S., Wardelmann, E., Nilsson, B., Sihto, H., Bono, P., Kallio, R., Junnila, J., Thor Alvegård & Reichardt, P., 2015, In : Journal of Clinical Oncology.

    Research output: Contribution to journalArticle

  44. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

    Jóhannsson, O. T., J Ranstam, Åke Borg & Håkan Olsson, 1998 Feb, In : Journal of Clinical Oncology. 16, 2, p. 397-404

    Research output: Contribution to journalArticle

  45. Quality of life in palliative cancer care: results from a cluster randomized trial

    Jordhoy, M. S., Fayers, P., Loge, J. H., Ahlner-Elmqvist, M. & Kaasa, S., 2001, In : Journal of Clinical Oncology. 19, 18, p. 3884-3894

    Research output: Contribution to journalArticle

  46. Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

    Kaiser, U., Uebelacker, L., Abel, U., Birkmann, J., Trumper, L., Schmalenberg, H., Karakas, T., Metzner, B., Hossfeld, DK., Bischoff, HG., Franke, A., Reiser, M., Muller, P., Mantovani, L., Grundeis, M., Rothmann, F., von Seydewitz, CU., Mesters, RM., Steinhauer, EU., Krahl, D. & 9 othersSchumacher, K., Kneba, M., Baudis, M., Schmitz, N., Pfab, R., Koppler, H., Parwaresch, R., Pfreundschuh, M. & Havemann, K., 2002, In : Journal of Clinical Oncology. 20, 22, p. 4413-4419

    Research output: Contribution to journalArticle

  47. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation.

    Kaufman, B., Shapira-Frommer, R., Schmutzler, R. K., Audeh, M. W., Friedlander, M., Balmaña, J., Mitchell, G., Fried, G., Stemmer, S. M., Hubert, A., Rosengarten, O., Steiner, M., Niklas Loman, Bowen, K., Fielding, A. & Domchek, S. M., 2015, In : Journal of Clinical Oncology. 33, 3, p. 244-U134

    Research output: Contribution to journalArticle

  48. Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia.

    Knauf, W. U., Lissichkov, T., Aldaoud, A., Liberati, A., Loscertales, J., Herbrecht, R., Gunnar Juliusson, Postner, G., Gercheva, L., Goranov, S., Becker, M., Fricke, H-J., Huguet, F., Del Giudice, I., Klein, P., Tremmel, L., Merkle, K. & Montillo, M., 2009, In : Journal of Clinical Oncology. 27, p. 4378-4384

    Research output: Contribution to journalArticle

  49. Absolute Risk Prediction of Second Primary Thyroid Cancer Among 5-Year Survivors of Childhood Cancer.

    Kovalchik, S. A., Ronckers, C. M., Veiga, L. H. S., Sigurdson, A. J., Inskip, P. D., de Vathaire, F., Sklar, C. A., Donaldson, S. S., Anderson, H., Bhatti, P., Hammond, S., Leisenring, W. M., Mertens, A. C., Smith, S. A., Stovall, M., Tucker, M. A., Weathers, R. E., Robison, L. L. & Pfeiffer, R. M., 2012, In : Journal of Clinical Oncology.

    Research output: Contribution to journalArticle

  50. Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer.

    Kreimer, A. R., Johansson, M., Waterboer, T., Kaaks, R., Chang-Claude, J., Drogen, D., Tjønneland, A., Overvad, K., Quirós, J. R., González, C. A., Sánchez, M. J., Larrañaga, N., Navarro, C., Barricarte, A., Travis, R. C., Khaw, K-T., Wareham, N., Trichopoulou, A., Lagiou, P., Trichopoulos, D. & 22 othersPeeters, P. H. M., Panico, S., Masala, G., Grioni, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, H. B., Laurell, G., Hallmans, G., Jonas Manjer, Ekström, J., Skeie, G., Lund, E., Weiderpass Vainio, E., Ferrari, P., Byrnes, G., Romieu, I., Riboli, E., Hildesheim, A., Boeing, H., Pawlita, M. & Brennan, P., 2013, In : Journal of Clinical Oncology. 31, 21, p. 2708

    Research output: Contribution to journalArticle

  51. Double-blind, placebo-controlled, randomized phase III trial evaluating pertuzumab combined with chemotherapy for low tumor human epidermal growth factor receptor 3 mRNA-Expressing platinum-resistant ovarian Cancer (PENELOPE)

    Kurzeder, C., Bover, I., Marḿe, F., Rau, J., Pautier, P., Colombo, N., Lorusso, D., Ottevanger, P., Bjurberg, M., Marth, C., Barretina-Ginesta, P., Vergote, I., Floquet, A., Campo, J. M. D., Mahner, S., Bastíere-Truchot, L., Martin, N., Oestergaard, M. Z., Kiermaier, A., Schade-Brittinger, C. & 3 othersPolleis, S., Bois, A. D. & Gonzalez-Martin, A., 2016 Jul 20, In : Journal of Clinical Oncology. 34, 21, p. 2516-25 10 p.

    Research output: Contribution to journalArticle

  52. Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial.

    Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., van den Berg, H., Dirksen, U., Lars Hjorth, Michon, J., Lewis, I., Craft, A. & Jürgens, H., 2010, In : Journal of Clinical Oncology. Jul 1, p. 3284-3291

    Research output: Contribution to journalArticle

  53. Surveillance for late effects in childhood cancer survivors

    Landier, W., Skinner, R., Wallace, W. H., Lars Hjorth, Mulder, R. L., Wong, F. L., Yasui, Y., Bhakta, N., Constine, L. S., Bhatia, S., Kremer, L. C. & Hudson, M. M., 2018 Jul 20, In : Journal of Clinical Oncology. 36, 21, p. 2216-2222 7 p.

    Research output: Contribution to journalReview article

  54. Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial.

    Le Deley, M-C., Paulussen, M., Lewis, I., Brennan, B., Ranft, A., Whelan, J., Le Teuff, G., Michon, J., Ladenstein, R., Marec-Bérard, P., van den Berg, H., Lars Hjorth, Wheatley, K., Judson, I., Juergens, H., Craft, A., Oberlin, O. & Dirksen, U., 2014, In : Journal of Clinical Oncology. 32, 23, p. 2440-2448

    Research output: Contribution to journalArticle

  55. Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer.

    Lehmann, S., Bykov, V. J. N., Ali, D., Andrén, O., Cherif, H., Tidefelt, U., Uggla, B., Yachnin, J., Gunnar Juliusson, Moshfegh, A., Paul, C., Wiman, K. G. & Andersson, P-O., 2012, In : Journal of Clinical Oncology. 30, 29, p. 3633-3639

    Research output: Contribution to journalArticle

  56. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

    Hans Lilja, David Ulmert, Thomas Björk, Charlotte Becker, Serio, A. M., Nilsson, J-A., Abrahamsson, P-A., Vickers, A. J. & Berglund, G., 2007, In : Journal of Clinical Oncology. 25, 4, p. 431-436

    Research output: Contribution to journalArticle

  57. Improving Surveillance and Quality of Life of BRCA Mutation Carriers.

    Niklas Loman & Åke Borg, 2010, In : Journal of Clinical Oncology. 28, p. E376-E377

    Research output: Contribution to journalArticle

  58. Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma.

    Ludwig, H., Bolejack, V., Crowley, J., Bladé, J., San Miguel, J., Kyle, R. A., Rajkumar, S. V., Shimizu, K., Ingemar Turesson, Westin, J., Sonneveld, P., Cavo, M., Boccadoro, M., Palumbo, A., Tosi, P., Harousseau, J-L., Attal, M., Barlogie, B., Stewart, A. K. & Durie, B., 2010, In : Journal of Clinical Oncology. 28, p. 1599-1605

    Research output: Contribution to journalArticle

  59. Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2.

    Malone, K. E., Begg, C. B., Haile, R. W., Åke Borg, Concannon, P., Tellhed, L., Xue, S., Teraoka, S., Bernstein, L., Capanu, M., Reiner, A. S., Riedel, E. R., Thomas, D. C., Mellemkjær, L., Lynch, C. F., Boice, J. D., Anton-Culver, H. & Bernstein, J. L., 2010, In : Journal of Clinical Oncology. 28, p. 2404-2410

    Research output: Contribution to journalArticle

  60. International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell Lymphoma

    Maurer, M. J., Fredrik Ellin, Srour, L., Mats Jerkeman, Bennani, N. N., Connors, J. M., Slack, G. W., Smedby, K. E., Ansell, S. M., Link, B. K., Cerhan, J. R., Relander, T., Savage, K. J. & Feldman, A. L., 2017 Dec 20, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 36, p. 4019-4026 8 p.

    Research output: Contribution to journalArticle

  61. Immunotherapy for Glioblastoma: The Devil Is in the Details Reply

    Mehta, A. I., Persson, O., Herndon, J. E. . II., Archer, G. E., McLendon, R., Heimberger, A. B., Mitchell, D. A., Bigner, D. D. & Sampson, J. H., 2011, In : Journal of Clinical Oncology. 29, 22, p. 3105-3106

    Research output: Contribution to journalLetter

  62. Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.

    Olle Melander, Marju Orho-Melander, Jonas Manjer, Svensson, T., Almgren, P., Peter Nilsson, Gunnar Engström, Bo Hedblad, Signe Borgquist, Hartmann, O., Struck, J., Bergmann, A. & Mattias Belting, 2015, In : Journal of Clinical Oncology. 33, 24, p. 2632-U81

    Research output: Contribution to journalArticle

  63. Serum biomarker signature-based liquid biopsy for diagnosis of early-stage pancreatic cancer

    Mellby, L. D., Nyberg, A. P., Johansen, J. S., Christer Wingren, Nordestgaard, B. G., Bojesen, S. E., Mitchell, B. L., Sheppard, B. C., Sears, R. C. & Carl A.K. Borrebaeck, 2018, In : Journal of Clinical Oncology. 36, 28, p. 2887-2894 8 p.

    Research output: Contribution to journalArticle

  64. Prognostic Significance of Chromosome Aberrations in High-Grade Soft Tissue Sarcomas.

    Fredrik Mertens, Strömberg, U., Anders Rydholm, Pelle Gustafson, Bauer, H. C. F., Brosjo, O. & Nils Mandahl, 2006, In : Journal of Clinical Oncology. 24, 2, p. 315-320

    Research output: Contribution to journalArticle

  65. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries

    Möller, T. R., Garwicz, S., Barlow, L., Falck Winther, J., Glattre, E., Olafsdottir, G., Olsen, J. H., Perfekt, R., Ritvanen, A., Sankila, R. & Tulinius, H., 2001, In : Journal of Clinical Oncology. 19, 13, p. 3173-3181

    Research output: Contribution to journalArticle

  66. Gemcitabine Plus Docetaxel Versus Docetaxel in Patients With Predominantly Human Epidermal Growth Factor Receptor 2–Negative Locally Advanced or Metastatic Breast Cancer: A Randomized, Phase III Study by the Danish Breast Cancer Cooperative Group

    Nielsen, D. L., Bjerre, K. D., Jakobsen, E. H., Cold, S., Stenbygaard, L., Sørensen, P. G., Kamby, C., Møller, S., Charlotte Levin Tykjaer Jörgensen & Andersson, M., 2011, In : Journal of Clinical Oncology. 29, 36, p. 4748-4754

    Research output: Contribution to journalArticle

  67. Role for Genetic Anticipation in Lynch Syndrome.

    Mef Nilbert, Timshel, S., Bernstein, I. & Larsen, K., 2009, In : Journal of Clinical Oncology. 27, p. 360-364

    Research output: Contribution to journalArticle

  68. Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA

    Olofsson, S., Dahl, O., Mats Jerkeman, Cohn-Cedermark, G., Klepp, O., Stierner, U., Tornblom, M., Wahlqvist, R. & Cavallin-Ståhl, E., 2009, In : Journal of Clinical Oncology. 27, 15

    Research output: Contribution to journalPublished meeting abstract

  69. Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer Group.

    Olofsson, S-E., Tandstad, T., Mats Jerkeman, Dahl, O., Ståhl, O., Klepp, O., Bremnes, R. M., Cohn-Cedermark, G., Langberg, C. W., Laurell, A., Solberg, A., Stierner, U., Wahlqvist, R., Wijkström, H., Anderson, H. & Cavallin-Ståhl, E., 2011, In : Journal of Clinical Oncology. 29, p. 2032-2039

    Research output: Contribution to journalArticle

  70. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis

    Petersen, P. M., Aleksander Giwercman, Daugaard, G., Rorth, M., Petersen, J. H., Skakkeaek, N. E., Hansen, S. W. & von der Maase, H., 2002, In : Journal of Clinical Oncology. 20, 6, p. 1537

    Research output: Contribution to journalArticle

  71. Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.

    Phillips, K-A., Milne, R. L., Rookus, M. A., Daly, M. B., Antoniou, A. C., Peock, S., Frost, D., Easton, D. F., Ellis, S., Friedlander, M. L., Buys, S. S., Andrieu, N., Noguès, C., Stoppa-Lyonnet, D., Bonadona, V., Pujol, P., McLachlan, S. A., John, E. M., Hooning, M. J., Seynaeve, C. & 16 othersTollenaar, R. A. E. M., Goldgar, D. E., Terry, M. B., Caldes, T., Weideman, P. C., Andrulis, I. L., Singer, C. F., Birch, K., Simard, J., Southey, M. C., Håkan Olsson, Jakubowska, A., Olah, E., Gerdes, A-M., Foretova, L. & Hopper, J. L., 2013, In : Journal of Clinical Oncology. 31, 25, p. 3091

    Research output: Contribution to journalArticle

  72. Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity.

    Poplin, E., Wasan, H., Rolfe, L., Raponi, M., Ikdahl, T., Bondarenko, I., Davidenko, I., Bondar, V., Garin, A., Boeck, S., Ormanns, S., Heinemann, V., Bassi, C., Evans, T. R. J., Andersson, R., Hahn, H., Picozzi, V., Dicker, A., Mann, E., Voong, C. & 3 othersKaur, P., Isaacson, J. & Allen, A., 2013, In : Journal of Clinical Oncology. 31, 35, p. 4453-4461

    Research output: Contribution to journalArticle

  73. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer

    Renkonen, E., Zhang, YG., Lohi, H., Salovaara, R., Abdel-Rahman, WM., Mef Nilbert, Aittomaki, K., Jarvinen, HJ., Mecklin, JP., Lindblom, A. & Peltomaki, P., 2003, In : Journal of Clinical Oncology. 21, 19, p. 3629-3637

    Research output: Contribution to journalArticle

  74. Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome?

    Johan Richter, Söderlund, S., Lübking, A., Dreimane, A., Lotfi, K., Markevärn, B., Själander, A., Saussele, S., Olsson-Strömberg, U. & Stenke, L., 2014, In : Journal of Clinical Oncology. 32, 25, p. 2821-2823

    Research output: Contribution to journalLetter

  75. t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma

    Roulland, S., Kelly, R. S., Morgado, E., Sungalee, S., Solal-Celigny, P., Colombat, P., Jouve, N., Palli, D., Pala, V., Tumino, R., Panico, S., Sacerdote, C., Quiros, J. R., Gonzales, C. A., Sanchez, M-J., Dorronsoro, M., Navarro, C., Barricarte, A., Tjonneland, A., Olsen, A. & 29 othersOvervad, K., Canzian, F., Kaaks, R., Boeing, H., Drogan, D., Nieters, A., Clavel-Chapelon, F., Trichopoulou, A., Trichopoulos, D., Lagiou, P., Bueno-de-Mesquita, H. B., Peeters, P. H. M., Vermeulen, R., Hallmans, G., Melin, B., Signe Borgquist, Joyce Carlson, Lund, E., Weiderpass, E., Khaw, K-T., Wareham, N., Key, T. J., Travis, R. C., Ferrari, P., Romieu, I., Riboli, E., Salles, G., Vineis, P. & Nadel, B., 2014, In : Journal of Clinical Oncology. 32, 13, p. 1347

    Research output: Contribution to journalArticle

  76. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: Role of allogeneic stem-cell transplantation in Nordic data

    Saarinen-Pihkala, U. M., Heilmann, C., Winiarski, J., Glomstein, A., Abrahamsson, J., Arvidson, J., Békássy, A., Forestier, E., Jonmundsson, G., Schroeder, H., Vettenranta, K., Wesenberg, F. & Gustafsson, G., 2006, In : Journal of Clinical Oncology. 24, 36, p. 5750-5762

    Research output: Contribution to journalArticle

  77. Emergence of New ALK Mutations at Relapse of Neuroblastoma.

    Schleiermacher, G., Javanmardi, N., Bernard, V., Leroy, Q., Cappo, J., Rio Frio, T., Pierron, G., Lapouble, E., Combaret, V., Speleman, F., de Wilde, B., Djos, A., Øra, I., Hedborg, F., Träger, C., Holmqvist, B-M., Abrahamsson, J., Peuchmaur, M., Michon, J., Janoueix-Lerosey, I. & 3 othersKogner, P., Delattre, O. & Martinsson, T., 2014, In : Journal of Clinical Oncology. 32, 25, p. 2727

    Research output: Contribution to journalArticle

  78. 90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial.

    Scholz, C. W., Pinto, A., Linkesch, W., Lindén, O., Viardot, A., Keller, U., Hess, G., Lastoria, S., Lerch, K., Frigeri, F., Arcamone, M., Stroux, A., Frericks, B., Pott, C. & Pezzutto, A., 2013, In : Journal of Clinical Oncology. 31, 3, p. 308-313

    Research output: Contribution to journalArticle

  79. Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the Swedish Breast Cancer Group 91 radiotherapy randomized clinical trial

    Martin Sjöström, Lundstedt, D., Linda Hartman, Holmberg, E., Killander, F., Kovács, A., Per Malmström, Emma Niméus, Rönnerman, E. W., Mårten Fernö & Karlsson, P., 2017 Oct 1, In : Journal of Clinical Oncology. 35, 28, p. 3222-3229 8 p.

    Research output: Contribution to journalArticle

  80. Influence on the Health of the Partner Affected by Tumor Disease in the Wife or Husband Based on a Population-Based Register Study of Cancer in Sweden.

    Sjövall, K., Attner, B., Lithman, T., Noreen, D., Gunnars, B., Thomé, B. & Håkan Olsson, 2009, In : Journal of Clinical Oncology. 27, p. 4781-4786

    Research output: Contribution to journalArticle

  81. Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome

    Skotheim, RI., Kallioniemi, A., Bjerkhagen, B., Fredrik Mertens, Brekke, HR., Monni, O., Mousses, S., Mandahl, N., Saeter, G., Nesland, JM., Smeland, S., Kallioniemi, OP. & Lothe, RA., 2003, In : Journal of Clinical Oncology. 21, 24, p. 4586-4591

    Research output: Contribution to journalArticle

  82. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition

    Stephenson, A. J., Kattan, M. W., Eastham, J. A., Dotan, Z. A., Bianco, F. J. J., Hans Lilja & Scardino, P. T., 2006, In : Journal of Clinical Oncology. 24, 24, p. 3973-3978

    Research output: Contribution to journalArticle

  83. Randomized, double-blind, placebo-controlled phase III study of tasquinimod in men with metastatic castration-resistant prostate cancer

    Sternberg, C., Armstrong, A., Pili, R., Ng, S., Huddart, R., Agarwal, N., Khvorostenko, D., Lyulko, O., Brize, A., Vogelzang, N., Delva, R., Harza, M., Thanos, A., James, N., Werbrouck, P., Bögemann, M., Hutson, T., Milecki, P., Chowdhury, S., Gallardo, E. & 6 othersSchwartsmann, G., Pouget, J. C., Baton, F., Nederman, T., Tuvesson, H. & Carducci, M., 2016 Aug 1, In : Journal of Clinical Oncology. 34, 22, p. 2636-2643 8 p.

    Research output: Contribution to journalArticle

  84. Risk of second cancer in Hodgkin lymphoma survivors and influence of family history

    Sud, A., Hauke Thomsen, Kristina Sundquist, Houlston, R. S. & Kari Hemminki, 2017 May 10, In : Journal of Clinical Oncology. 35, 14, p. 1584-1590 7 p.

    Research output: Contribution to journalArticle

  85. Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group (SWENOTECA).

    Tandstad, T., Smaaland, R., Solberg, A., Bremnes, R. M., Langberg, C. W., Laurell, A., Stierner, U. K., Ståhl, O., Cavallin-Ståhl, E., Klepp, O. H., Dahl, O. & Cohn-Cedermark, G., 2011, In : Journal of Clinical Oncology. 29, 4, p. 719-725

    Research output: Contribution to journalArticle

  86. Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program.

    Tandstad, T., Dahl, O., Cohn-Cedermark, G., Cavallin-Ståhl, E., Stierner, U., Solberg, A., Langberg, C., Bremnes, R. M., Laurell, A., Wijkstrøm, H. & Klepp, O., 2009, In : Journal of Clinical Oncology. 27, p. 2122-2128

    Research output: Contribution to journalArticle

  87. Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401.

    Tanner, M., Isola, J., Wiklund, T., Erikstein, B., Kellokumpu-Lehtinen, P., Per Malmström, Wilking, N., Nilsson, J. & Bergh, J., 2006, In : Journal of Clinical Oncology. 24, 16, p. 2428-2436

    Research output: Contribution to journalArticle

  88. Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.

    Tanner, MM., Isola, JJ., Wiklund, T., Erikstein, B., Kellokumpu-Lehtinen, P., Per Malmström, Wilking, N., Nilsson, J. & Bergh, J., 2005, In : Journal of Clinical Oncology. 23, 16S, p. 841S-841S

    Research output: Contribution to journalPublished meeting abstract

  89. International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease.

    Terpos, E., Morgan, G., Dimopoulos, M. A., Drake, M. T., Lentzsch, S., Raje, N., Sezer, O., García-Sanz, R., Shimizu, K., Ingemar Turesson, Reiman, T., Jurczyszyn, A., Merlini, G., Spencer, A., Leleu, X., Cavo, M., Munshi, N., Rajkumar, S. V., Durie, B. G. M. & Roodman, G. D., 2013, In : Journal of Clinical Oncology. 31, 18, p. 2347-U179

    Research output: Contribution to journalArticle

  90. Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors

    Timmerman, D., Van Calster, B., Jurkovic, D., Lil Valentin, Testa, A. C., Bernard, J-P., Van Holsbeke, C., Van Huffel, S., Vergote, I. & Bourne, T., 2007, In : Journal of Clinical Oncology. 25, 27, p. 4194-4200

    Research output: Contribution to journalArticle

Previous 1 2 Next